Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Natural Killer (NK) Cell Therapeutics
1.2 Key Market Segments
1.2.1 Natural Killer (NK) Cell Therapeutics Segment by Type
1.2.2 Natural Killer (NK) Cell Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Natural Killer (NK) Cell Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Natural Killer (NK) Cell Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Natural Killer (NK) Cell Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Natural Killer (NK) Cell Therapeutics Market Competitive Landscape
3.1 Global Natural Killer (NK) Cell Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Natural Killer (NK) Cell Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Natural Killer (NK) Cell Therapeutics Sales Sites, Area Served, Product Type
3.6 Natural Killer (NK) Cell Therapeutics Market Competitive Situation and Trends
3.6.1 Natural Killer (NK) Cell Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Natural Killer (NK) Cell Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Natural Killer (NK) Cell Therapeutics Industry Chain Analysis
4.1 Natural Killer (NK) Cell Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Natural Killer (NK) Cell Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Natural Killer (NK) Cell Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Natural Killer (NK) Cell Therapeutics Price by Type (2019-2024)
7 Natural Killer (NK) Cell Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Natural Killer (NK) Cell Therapeutics Market Sales by Application (2019-2024)
7.3 Global Natural Killer (NK) Cell Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Natural Killer (NK) Cell Therapeutics Sales Growth Rate by Application (2019-2024)
8 Natural Killer (NK) Cell Therapeutics Market Segmentation by Region
8.1 Global Natural Killer (NK) Cell Therapeutics Sales by Region
8.1.1 Global Natural Killer (NK) Cell Therapeutics Sales by Region
8.1.2 Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Natural Killer (NK) Cell Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Natural Killer (NK) Cell Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Natural Killer (NK) Cell Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Natural Killer (NK) Cell Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Chipscreen Biosciences
9.1.1 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Basic Information
9.1.2 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Overview
9.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Market Performance
9.1.4 Chipscreen Biosciences Business Overview
9.1.5 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics SWOT Analysis
9.1.6 Chipscreen Biosciences Recent Developments
9.2 Affimed NV
9.2.1 Affimed NV Natural Killer (NK) Cell Therapeutics Basic Information
9.2.2 Affimed NV Natural Killer (NK) Cell Therapeutics Product Overview
9.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Product Market Performance
9.2.4 Affimed NV Business Overview
9.2.5 Affimed NV Natural Killer (NK) Cell Therapeutics SWOT Analysis
9.2.6 Affimed NV Recent Developments
9.3 Altor BioScience
9.3.1 Altor BioScience Natural Killer (NK) Cell Therapeutics Basic Information
9.3.2 Altor BioScience Natural Killer (NK) Cell Therapeutics Product Overview
9.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Product Market Performance
9.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics SWOT Analysis
9.3.5 Altor BioScience Business Overview
9.3.6 Altor BioScience Recent Developments
9.4 Innate Pharma
9.4.1 Innate Pharma Natural Killer (NK) Cell Therapeutics Basic Information
9.4.2 Innate Pharma Natural Killer (NK) Cell Therapeutics Product Overview
9.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Product Market Performance
9.4.4 Innate Pharma Business Overview
9.4.5 Innate Pharma Recent Developments
9.5 Takeda
9.5.1 Takeda Natural Killer (NK) Cell Therapeutics Basic Information
9.5.2 Takeda Natural Killer (NK) Cell Therapeutics Product Overview
9.5.3 Takeda Natural Killer (NK) Cell Therapeutics Product Market Performance
9.5.4 Takeda Business Overview
9.5.5 Takeda Recent Developments
9.6 Sorrento Therapeutics
9.6.1 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Basic Information
9.6.2 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Overview
9.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Market Performance
9.6.4 Sorrento Therapeutics Business Overview
9.6.5 Sorrento Therapeutics Recent Developments
9.7 NantKwest
9.7.1 NantKwest Natural Killer (NK) Cell Therapeutics Basic Information
9.7.2 NantKwest Natural Killer (NK) Cell Therapeutics Product Overview
9.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Product Market Performance
9.7.4 NantKwest Business Overview
9.7.5 NantKwest Recent Developments
9.8 Bristol-Myers Squibb
9.8.1 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Basic Information
9.8.2 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Overview
9.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Market Performance
9.8.4 Bristol-Myers Squibb Business Overview
9.8.5 Bristol-Myers Squibb Recent Developments
9.9 NKT
9.9.1 NKT Natural Killer (NK) Cell Therapeutics Basic Information
9.9.2 NKT Natural Killer (NK) Cell Therapeutics Product Overview
9.9.3 NKT Natural Killer (NK) Cell Therapeutics Product Market Performance
9.9.4 NKT Business Overview
9.9.5 NKT Recent Developments
9.10 Henry Ford Health Services
9.10.1 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Basic Information
9.10.2 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Overview
9.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Market Performance
9.10.4 Henry Ford Health Services Business Overview
9.10.5 Henry Ford Health Services Recent Developments
10 Natural Killer (NK) Cell Therapeutics Market Forecast by Region
10.1 Global Natural Killer (NK) Cell Therapeutics Market Size Forecast
10.2 Global Natural Killer (NK) Cell Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Natural Killer (NK) Cell Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size Forecast by Region
10.2.4 South America Natural Killer (NK) Cell Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Natural Killer (NK) Cell Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Natural Killer (NK) Cell Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Natural Killer (NK) Cell Therapeutics by Type (2025-2030)
11.1.2 Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Natural Killer (NK) Cell Therapeutics by Type (2025-2030)
11.2 Global Natural Killer (NK) Cell Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Natural Killer (NK) Cell Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Natural Killer (NK) Cell Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings